 YARDLEY, Pa., April 08, 2022 GLOBE NEWSWIRE -- Optinose NASDAQ:OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 12, 2022 at 11:45 a.m. ET. 